Cerebrospinal fluid transferrin II studies in ischemic disorders of the central nervous system.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002561:Cerebrovascular Disorders / Q000134:cerebrospinal fluid*; D002648:Child; D002675:Child, Preschool; D003704:Dementia / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007223:Infant; D002546:Ischemic Attack, Transient / Q000134:cerebrospinal fluid; D008180:Lupus Erythematosus, Systemic / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid; D009896:Optic Atrophy / Q000134:cerebrospinal fluid; D009902:Optic Neuritis / Q000134:cerebrospinal fluid; D011115:Polyneuropathies / Q000134:cerebrospinal fluid; D013344:Subacute Sclerosing Panencephalitis / Q000134:cerebrospinal fluid; D014168:Transferrin / Q000097:blood / Q000134:cerebrospinal fluid*
D002556:Cerebrospinal Fluid Proteins; D014168:Transferrin